Publication

A glimpse into the future of model-informed drug discovery and development

Explore the future of Model-Informed Drug Development (MIDD), including advances in pharmacometrics, PBPK, QSP, precision…

Certara2026年8月28日

Webinar

The Road to First-in-Human: Model-Informed Decisions from Discovery to First Dose

Danielle Pillsbury2026年8月28日

Live Events

Tailwinds for MIDD: What to Know About the Changing Regulatory Landscape

2026年9月30日 - 11:30 PM – 2:00 PM

Certara2026年8月12日

Live Events

2026 SEND Explorer Virtual User Group Meeting

–

Danielle Pillsbury2026年7月16日

Webinar

Integrated mechanistic modeling approaches in oncology drug development

Certara2026年7月8日

Blog

Dosimetry for radiopharmaceutical therapy: From measurement to dose justification

Why dosimetry for radiopharmaceutical therapy needs more than absorbed dose. How BED, radiation dosimetry &…

Hunter Stephens, PhD2026年7月7日

Blog

リアルワールドエビデンスを活用した妊娠研究における臨床試験の強化

Learn how real-world evidence improves clinical trials in pregnancy by enhancing safety data, trial design,…

Alekhya Lavu, PhD, PharmD2026年6月26日

Poster

Mechanistic Modelling of CRS in T-cell Engagers – An Application for Blinatumomab

Discover how Quantitative Systems Pharmacology (QSP) was used to predict cytokine release syndrome risk and…

Certara2026年6月23日

Announcement

Certara Integrates D360™ with Secondary Intelligence™ Software to Enhance Predicting Drug Safety Risk

Certara integrates D360 with Secondary Intelligence to help drug researchers identify off-target safety risks earlier…

Certara2026年6月12日

On-Demand Webinar

BioSpace webinar: Streamlining Nonclinical Development with FDA NAMs

Learn how to apply FDA NAM guidance to streamline nonclinical development, support IND decisions, and…

Certara2026年5月8日

Powered by Translations.com GlobalLink Web Software

薬物安全性